Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells

THOD - Turk Hematoloji-Onkoloji Dergisi

Volumn 13, Issue 3, 2003, Pages 125-133

  Aysun, Özkan ^a   Kayahan, Fişkin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Epirubicin HCI; GSH; GSH Px; GST; NSCLC

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; CATALASE; CYTOTOXIC AGENT; EPIRUBICIN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TETRAZOLIUM;

ARTICLE; CANCER CELL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DEFENSE MECHANISM; ELECTRON; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; INTRACELLULAR MEMBRANE; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TIME;

EID: 0141842775     PISSN: 13018825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bachur NR, Gordon SL, Gee MV. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38: 1745-1750, 1978.
2. Banadonna G. Advances in anthracycline chemotherapy: Epirubicin-HCI. Masson Italia Editori, Milano, 1984.
3. Bachur NR, Gee MV, Friedman R.D. Nuclear-catalysed antibiotic free radical formation. Cancer Res 42: 1078-1081, 1982.
4. Iyanagi T, Yamazaki I. One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim Biophys Acta 216: 282-294, 1970.
5. Begleiter A. Cytocidal action of the quinone group and its relationship to antitumour activity. Cancer Res 43: 481-484, 1983.
6. Buttke TM, Sandstorm PA. Oxidative stress as a mediator of programmed cell death. Immunol. Today 1: 15-17, 1994.
7. Akkuş I. Serbest radikaller ve fizyopatolojik etkileri. Konya Mimoza Basim Yayin ve Daǧitim, 1995.
8. Lind C, Hocgstein P, Ernster L. DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation. Arch Biochem Biophys 21: 6178-185, 1982.
9. Chen S, Wang J, Chen J, Huang R. Possible involvement of glutathione and p53 in trichloroethylene and perchloroethylene-induced lipid peroxidation and apoptosis in human lung cancer cells. Free Radic Biol Med 15;33(4): 464-470, 2002.
10. Yang GY, Liao J, Kim K, et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogen 19(4): 611-616, 1998.
11. Zhou J, Zhu Q, Yao H. Chemotherapy of non-small-cell lung cancer (NSCLC) and changes in serum sAPO-1/Fas and nitric oxide (NO) levels. Zhongh Zhong Liu Za Zhi 22(3): 225-227, 2000.
12. Synder HS, Bredt DS. Biological roles of nitric oxide. Sci American 5: 28.34, 1992.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-65, 1983.
14. Habig WH, Jakoby WB. Assay for differentiation of glutathione S- transferases. Methods in Enzymolog 77: 398-405, 1981.
15. Flohe L, Gunzler WA. Glutathione peroxidase. Methods Enzymol 105: 115-121, 1984.
16. Beutler E. Glutathione peroxidase. In Red Cell Metabolism: A Manual of Biochemical Methods, Grune & Stratton: New York 71-73, 1975.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72: 248-254, 1976.
18. Maniatis T, Fritsch E, F, Sambrok J. Molecular cloning: A laboratory manual. New York; Cold Spring Harbor Laboratory, 1982.
19. Duncan D.B. Multiple range and multiple F test. Biometrics 11: 1-14, 1955.
20. Snedocor GW, Cochran WG. Statistical methods. 6th ed. Ames, Iowa U.S.A. Iowa State University Press, 1967.
21. Sinha BK. 1989. Free radicals in anticancer drug pharmacology. Chem Biol Interact 69: 293-317, 1989.
22. Gutteridge JMC, Halliwel B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15: 129-135, 1990.
23. Myers CE, McGuire WP, Liss RH, Ifrim I, et al. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumour response. Science 197: 165-167, 1977.
24. Siegusmund DMJ, Steidler A, Kreukler C, et al. Enhanced in vitro cytotoxicity of idarubicin in rat prostate carcinoma cells. Eur Urol 31: 365-370, 1997.
25. Frusawa S, Nakana S, Wada M, et al. Augmentation of epirubicin-HCI cytotoxicity by cycloheximide. Res Commun Mol Path Pharmacol 91: 245-252, 1996.
26. Davies SM, Robson CN, Davies SL, et al. Nuclear topoisomerse II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J Biol Chem 263: 17724-17729, 1988.
27. Julicher RHM, Sterremberg L, Bast A, et al. The role of lipid peroxidation in acute doxorubicin induced cardiotoxicity as studied in rat isolated heart. J Pharm Pharmacol 38: 277-282, 1986.
28. 2 in vitro and in vivo and reduce menadione-reduced DNA injury and cytotoxicity. Am J Physiol 37: 227-236, 1995.
29. Hao XY, Bergh J, Brodin O, et al. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogen 15: 1167-1173, 1994.
30. Kinnula K, Linnainma K, Raivio KO, et al. Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity. Brit J Cancer 7: 71097-71102, 1998.
31. Dierickx PJ. Glutathione-dependent cytotoxicity of the chloroacetanilide herbicides alachlor, metolachor, and propachlor in rat and human hepatoma-derived cultured cells. Cell Biol Toxicol 15: 325-332, 1999.
32. Ozkan A, Fiskin K. Investigation of effects of epirubicin-HCI and LAK on antioxidant mechanism and free radicals scavenger enzymes in hepatoma G2 cell line. Akdeniz Üniversitesi, Fen Edebiyat Fakültesi, Biyoloji Bölümü, Doktora Tezi, Antalya, 2003.
33. De Vries EGE, Meijer C, Timmer-Bosscha H, et al. Resistance mechanism in three human small cell lung cell lines established from one patient during clinical follow up. Cancer Res 49: 4174-4178, 1989.
34. Jeong D, Kim TS, Chung YW, et al. Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS 24(4): 225-228, 2002.
35. Hida T, Kuwabara M, Ariyoshi Y, et al. Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response. Cancer 1(5): 1377-1382, 1994.
36. Montironi R, Mazzucchelli R, Pomante R, et al. Immunohistochemical expression of p class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride. J Clin Pathol 52: 350-354, 1999.